Pediatric Vaccines Market, By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, and Other Technologies), By Vaccine Type (Monovalent, and Multivalent), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI407720 | Publish Date: March 2024 | No. of Pages: 178

Global Pediatric Vaccines Market By Overview

Pediatric Vaccines Market was valued at US$ 3.5 Billion in 2024 and is projected to grow at a CAGR of 7.5% to reach US$ 7.2 Billion by 2034.

Pediatric vaccines are the vaccines used to prevent diseases such as pneumococcal disease, influenza, measles, mumps, and rubella and other diseases. The pediatric vaccines are given to the children up to a certain age to boost immunity against certain bacteria and virus. The Pediatric Vaccines Market has attained maturity, in terms of some of the disease segments (like polio), for some diseases the vaccines are not yet developed, so the market for vaccines is not yet getting mature.

Global Pediatric Vaccines Market By Dynamics

An increasing number of chronic diseases with the increasing awareness of immunization is the major propelling factor for the growth of the global market. For instance, as per the WHO (World Health Organization) in 2019, the 182 countries reported 364,808 measles cases. Additionally, the technical advancement in the vaccines is another driving factor for the growth of the target market. Moreover, the rise in government and non- government funding in the R&D to develop the vaccines which are the boosting factor for the growth of the global market. However, low medical coverage and healthcare services are the major restraining factor for the growth of the target market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Pediatric Vaccines Market By Segmentation

The pediatric vaccines market is segmented based on technology, vaccine type, application, and region.

Based on technology, the global pediatric vaccines market is segmented into live attenuated, inactivated, toxoid, conjugate, and other technologies. Based on the vaccine type, the global market is classified into monovalent, and multivalent. Based on the application, the target market is segmented into pneumococcal disease, influenza, measles, mumps, and rubella (MMR) and other applications.

 Regional Insights:

On the region, the pediatric vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia- Pacific region is dominating region in the pediatric vaccine market due to a rise in government funding for the vaccination and due to increasing population. The increasing awareness about vaccines in the Asia-Pacific region drives the growth of the global market.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

 Pediatric Vaccines Market, By Technology:

  • Live Attenuated
  • Inactivated
  • Toxoid
  • Conjugate
  • Other Technologies

Pediatric Vaccines Market, By Vaccine Type:

  • Monovalent
  • Multivalent

Pediatric Vaccines Market, By Application:

  • Pneumococcal Disease
  • Influenza
  • Measles, Mumps, and Rubella (MMR)
  • Other Applications

Pediatric Vaccines Market, By Region:

  • North America
    • North America Pediatric Vaccines Market, By Technology
    • North America Pediatric Vaccines Market, By Vaccine Type
    • North America Pediatric Vaccines Market, By Application
    • North America Pediatric Vaccines Market, By Country
      • U.S.
      • Canada
    • Europe
      • Europe Pediatric Vaccines Market, By Technology
      • Europe Pediatric Vaccines Market, By Vaccine Type
      • Europe Pediatric Vaccines Market, By Application
      • Europe Pediatric Vaccines Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Pediatric Vaccines Market, By Technology
      • Asia Pacific Pediatric Vaccines Market, By Vaccine Type
      • Asia Pacific Pediatric Vaccines Market, By Application
      • Asia Pacific Pediatric Vaccines Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific              
    • Latin America
      • Latin America Pediatric Vaccines Market, By Technology
      • Latin America Pediatric Vaccines Market, By Vaccine Type
      • Latin America Pediatric Vaccines Market, By Application
      • Latin America Pediatric Vaccines Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Middle East & Africa Pediatric Vaccines Market, By Technology
      • Middle East & Africa Pediatric Vaccines Market, By Vaccine Type
      • Middle East & Africa Pediatric Vaccines Market, By Application
      • Middle East & Africa Pediatric Vaccines Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Global Pediatric Vaccines Market By Key Players

The key players operating the pediatric vaccines market include GlaxoSmithKline PLC., Indian Immunologicals Limited, AstraZeneca, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson, Pfizer Inc., Sanofi SA, and Seqirus (CSL Limited). Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of Technology to gain a competitive edge in the target market. For instance, in 2018, GlaxoSmithKline PLC. signed an agreement with Novartis to secure full ownership of the consumer healthcare business.

Global Pediatric Vaccines Market By Company Profile

  • GlaxoSmithKline PLC
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Indian Immunologicals Limited
  • AstraZeneca
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi SA
  • Seqirus (CSL Limited)

“*” marked represents similar segmentation in other categories in the respective section

Global Pediatric Vaccines Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Pediatric Vaccines Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Technology
      • Market Snippet, By Vaccine Type
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Pediatric Vaccines Market, By Technology, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Live Attenuated
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Inactivated
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Toxiod
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Conjugate
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Technologies
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Pediatric Vaccines Market, By Vaccine Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Monovalent
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Multivalent
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Pediatric Vaccines Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pneumococcal Disease
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Influenza
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Measles, Mumps, and Rubella (MMR)
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others Applications
      • Overview
      • Market Pediatric Vaccines and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Pediatric Vaccines Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Pediatric Vaccines and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
    • GlaxoSmithKline PLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies
    • Indian Immunologicals Limited
    • AstraZeneca
    • Merck & Co. Inc.
    • Mitsubishi Tanabe Pharma Corporation
    • Johnson & Johnson
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus (CSL Limited)
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Pediatric Vaccines Module Market report segments the market been segmented on the based on technology, vaccine type, application, and region.

An increasing number of chronic diseases with the increasing awareness of immunization is the major propelling factor for the growth of the global market.

Asia- Pacific region is dominating region in the pediatric vaccine market

The leading players operating in the Pediatric Vaccines Module Market includes GlaxoSmithKline PLC., Indian Immunologicals Limited, AstraZeneca, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson, Pfizer Inc., Sanofi SA, and Seqirus (CSL Limited)